Skip to main content
Equibles

Rockefeller Capital Management L.P.

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1739439 NEW YORK, NY
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,400,777
+$586,453 QoQ
Shares Held
141,890
+0.3% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#83
of 330 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $308,249,937 across 242 Biotechnology names. NTLA ranks #18 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 149,476 $74,249,211
2 JAZZ
Jazz Pharmaceuticals plc
 167,409 $40,340,545
3 ACAD
Acadia Pharmaceuticals Inc
 1,015,420 $25,690,124
4 BMRN
Biomarin Pharmaceutical Inc
 433,376 $24,797,774
5 PTCT
Ptc Therapeutics, Inc.
 302,393 $24,666,195
6 MDGL
Madrigal Pharmaceuticals, Inc.
 29,015 $15,579,603
7 REGN
Regeneron Pharmaceuticals, Inc.
 21,563 $13,445,391
8 CORT
Corcept Therapeutics Inc
 123,388 $10,728,585

All Filings in NTLA

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,400,777 141,890
2026-03-31 $1,814,324 141,523
2025-12-31 $1,260,559 140,218
2025-09-30 $2,382,240 137,941
2025-06-30 $1,292,919 137,838
2025-03-31 $980,028 137,838
2024-12-31 $1,607,190 137,838
2024-09-30 $1,562,580 76,038
2024-06-30 $2,258,454 100,914
2024-03-31 $2,100,250 76,345
2023-12-31 $1,722,044 56,479
2023-09-30 $1,470,677 46,511
2023-06-30 $1,502,865 36,853
2023-03-31 $1,198,193 32,149
2022-12-31 $815,065 23,361
2022-09-30 $1,706,219 30,490
2022-06-30 $1,166,255 22,532
2022-03-31 $1,590,745 21,890
2021-12-31 $1,782,585 15,076
2021-09-30 $457,048 3,407
2021-06-30 $110,098 680
2021-03-31 $50,239 626
2020-12-31 $20,291 373
2020-09-30 $6,461 325